Delivery Order SPE2DB22D3016-SPE2DB25FATG3

Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $31,998.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, with a performance period ending on March 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. AmerisourceBergen Drug Corp holds an...
This federal contract award, valued at $14,221.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, with a performance period ending on May 29, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,110.80 firm fixed-price delivery order is for the supply of ENHERTU 100 MG vials, a specialty medication product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $10,099.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 mg vials, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a medical supply, with a ceiling value of $21,332.40. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a medical product, with a firm fixed price of $17,777.00 and a completion date of June 9, 2025. The contract is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,733.08 Firm Fixed Price Delivery Order is for the supply of ENHERTU 100 MG vials, a specialty oncology medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,777.00 firm fixed-price contract is for the supply of ENHERTU 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,777.00 Firm Fixed Price Delivery Order contract is for the supply of ENHERTU 100 MG VIALS, a medical product. The contract has an ultimate completion date of February 11, 2025 and was awarded on January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ENHERTU 100 MG VIALS, a medical product, with a ceiling value of $7,110.80 and a period of performance through July 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FATG3
    Delivery Order

This federal contract award, valued at $10,666.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a medical product, and has an ultimate completion date of April 28, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/7/25, 1:20 PM